Colorectal carcinoma (CRC) is the third most common cancer. Likewise, it is a disease that has a long survival if it is prematurely detected. However, more than 50% of patients will develop metastases, mainly in the liver (LM-CRC), throughout the evolution of their disease, which accounts for most CRC-related deaths. Treatment it is certainly a controversial issue, since it has not been shown to increase overall survival in the adjuvant setting, although it does improve disease free survival (DFS). Moreover, current chemotherapy combinations are administered based on data extrapolated from primary tumors (PT), not considering that LM-CRC present a very particular tumor microenvironment that can radically condition the effectiveness of treat...
The prognosis of patients with colorectal liver metastases (LMs) is mostly established on clinical v...
Surgical resection of colorectal liver metastases (CRLM) is the first choice of treatment when possi...
BACKGROUND: The histopathological growth patterns (HGPs) are a prognostic and predictive biomarker i...
Colorectal carcinoma (CRC) is the third most common cancer. Likewise, it is a disease that has a lon...
Almost half of all patients with colorectal cancer present with or eventually develop metastasis, mo...
A drastic difference exists between the 5-year survival rates of colorectal cancer patients with loc...
A drastic difference exists between the 5‐year survival rates of colorectal cancer patients with loc...
Colorectal cancer (CRC) is the third leading cause of cancer-related death worldwide. Metastasis is ...
Simple Summary In the era of immunotherapy, the tumor microenvironment (TME) has attracted special i...
Simple Summary In the era of immunotherapy, the tumor microenvironment (TME) has attracted special i...
In patients with colorectal cancer (CRC) that metastasizes to the liver, there are several key goal...
Introduction: Various potential prognostic histopathologic factors for colorectal carcinoma liver me...
Colorectal cancer is a major health burden and despite the recent advances in healthcare and screeni...
Introduction: Various potential prognostic histopathologic factors for colorectal carcinoma liver me...
The prognosis of patients with colorectal liver metastases (LMs) is mostly established on clinical v...
The prognosis of patients with colorectal liver metastases (LMs) is mostly established on clinical v...
Surgical resection of colorectal liver metastases (CRLM) is the first choice of treatment when possi...
BACKGROUND: The histopathological growth patterns (HGPs) are a prognostic and predictive biomarker i...
Colorectal carcinoma (CRC) is the third most common cancer. Likewise, it is a disease that has a lon...
Almost half of all patients with colorectal cancer present with or eventually develop metastasis, mo...
A drastic difference exists between the 5-year survival rates of colorectal cancer patients with loc...
A drastic difference exists between the 5‐year survival rates of colorectal cancer patients with loc...
Colorectal cancer (CRC) is the third leading cause of cancer-related death worldwide. Metastasis is ...
Simple Summary In the era of immunotherapy, the tumor microenvironment (TME) has attracted special i...
Simple Summary In the era of immunotherapy, the tumor microenvironment (TME) has attracted special i...
In patients with colorectal cancer (CRC) that metastasizes to the liver, there are several key goal...
Introduction: Various potential prognostic histopathologic factors for colorectal carcinoma liver me...
Colorectal cancer is a major health burden and despite the recent advances in healthcare and screeni...
Introduction: Various potential prognostic histopathologic factors for colorectal carcinoma liver me...
The prognosis of patients with colorectal liver metastases (LMs) is mostly established on clinical v...
The prognosis of patients with colorectal liver metastases (LMs) is mostly established on clinical v...
Surgical resection of colorectal liver metastases (CRLM) is the first choice of treatment when possi...
BACKGROUND: The histopathological growth patterns (HGPs) are a prognostic and predictive biomarker i...